Incidence of cytomegalovirus infection after allogeneic stem cell transplantation conditioned with myeloablative and non-myeloablative regimens

被引：0
|
作者：
Irrera, I
Morabito, F
Cuzzola, M
Cuzzocrea, A
Iacopino, O
Penna, G
Console, G
Messina, G
Martino, M
Iacopino, P
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [41] Correlation between MRD and chimerism kinetics in CLL patients after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation
    Plesa, Adriana
    Lee, Quoc-Hung
    Revesz, Daniela
    Thomas, Xavier
    Ducastelle, Sophie
    Nicolini, Franck E.
    Michallet, Anne-Sophie
    Mollet, Isabelle
    Dubois, Valerie
    Clark, Melisa
    Dumontet, Charles
    Raus, Nicole
    Michallet, Mauricette
    BLOOD, 2007, 110 (11) : 341B - 342B
  • [42] Dendritic cell recovery after non-myeloablative allogeneic stem cell transplantation is faster than after conventional transplantation
    Talarn, C
    Urbano-Ispizua, A
    Martino, R
    Batlle, M
    Herrera, C
    Simon, JAP
    Torrebadell, M
    Fernandez-Aviles, F
    Marin, P
    Sierra, J
    BONE MARROW TRANSPLANTATION, 2005, 35 : S195 - S196
  • [43] Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Hodgkin's Disease
    Hovgaard, Doris
    Sengelov, Henrik
    Vindelov, Lars
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S197 - S197
  • [44] High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation
    R Nakamura
    K Cortez
    S Solomon
    M Battiwalla
    VJ Gill
    N Hensel
    R Childs
    AJ Barrett
    Bone Marrow Transplantation, 2002, 30 : 235 - 242
  • [45] A comparison of non-myeloablative versus reduced conditioning for allogeneic stem cell transplantation
    Ringdén, O
    Le Blanc, K
    Uzunel, M
    Mattsson, J
    Barkholt, L
    Remberger, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S38 - S38
  • [46] A retrospective study of non-myeloablative allogeneic stem cell transplantation for lymphoma.
    Robinson, SP
    Mackinnon, S
    Goldstone, AH
    Slavin, S
    Carella, AM
    Russell, N
    Taghipour, G
    Schmitz, N
    BONE MARROW TRANSPLANTATION, 2001, 27 : S65 - S65
  • [47] Hemorrhagic toxoplasmosis after non-myeloablative condotioning therapy and allogeneic stem cell transplantation.
    Fuchs, M
    Stenzel, W
    Scheid, C
    Sasse, S
    Holtick, U
    Diehl, V
    Waldschmidt, DT
    BLOOD, 2002, 100 (11) : 438B - 438B
  • [48] Donor erythroid chimerism in mice after non-myeloablative allogeneic stem cell transplantation.
    Iannone, R
    Luznik, L
    Engstrom, LW
    Fuchs, EJ
    BLOOD, 1999, 94 (10) : 320B - 321B
  • [49] Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: Myeloablative, non-myeloablative, and beyond
    Hwang, Y. Y.
    Mohty, M.
    Chim, C. S.
    HEMATOLOGY, 2015, 20 (02) : 61 - 71
  • [50] Fludarabine/cyclophosphamide non-myeloablative allogeneic stem cell transplantation for lymphoid malignancies
    Auer, R. L.
    MacDougall, F.
    Oakervee, H. E.
    Cavenagh, J. C.
    Gribben, J. G.
    Lister, T. A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 70 - 70
12345